Is a complete ZNTL research report available?

No complete published report is available for Zentalis Pharmaceuticals, Inc. (ZNTL) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Zentalis Pharmaceuticals, Inc. (ZNTL)

NASDAQ: ZNTL · USD

$4.92

+0.25 (+5.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ZNTL analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	350.2M
Net income (ttm)	-124.1M
EPS (ttm)	-$1.74
Shares out	71.2M
Volume	1,002,869
Beta	1.93
Price target	$6.67	+35.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -124.1M
EPS (ttm): -$1.74
Market cap: 350.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ZNTL indicators

Market & fundamental data

Available fields

189

Groups with data

Currency

USD

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001725160
Company name	Zentalis Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	98943L107
Employees	106
Employees Change	-60%
Employees Change Percent	-36.14
Enterprise value	$177.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-04-03
Isin	US98943L1070
Last refreshed	2026-07-31
Market cap	$350.2M
Market cap category	Small-Cap
Price	$4.92
Price currency	USD
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2834
Symbol	ZNTL
Website	https://zentalis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-35.44%
FCF yield	-35.86%
P/B ratio	1.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-124.1M
Net Income Growth Quarters	4%
Net Income Growth Years	2%
Profit Per Employee	$-1.2M
ROA	-27.88
Roa5y	-27.42
ROCE	-66.58
ROE	-51.93
Roe5y	-53.29
ROIC	-31.78

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	264.77%
Cagr3y	-43.12%
Cagr5y	-38.21%
EPS Growth Quarters	4
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$253.1M
Cash	$211.8M
Current Assets	$218.1M
Current Liabilities	$35.2M
Debt	$38.7M
Debt Equity	$0.21
Equity	$182.7M
Liabilities	$70.4M
Long Term Assets	$35M
Long Term Liabilities	$35.2M
Net Cash	$173.1M
Net Cash By Market Cap	$49.43
Net Cash Growth	-40.37%
Net Debt Equity	$-0.95
Tangible Book Value	$182.7M
Tangible Book Value Per Share	$2.57
WACC	13.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.19
Net Working Capital	$-24.9M
Quick ratio	6.01
Working Capital	$182.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.34%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	264.44%
200-day SMA	2.92
3Y total return	-81.6%
50-day SMA	4.21
50-day SMA vs 200-day SMA	50over200
5Y total return	-90.99%
All Time High	87.19
All Time High Change	-94.36%
All Time High Date	2021-11-04
All Time Low	1.01
All Time Low Change	387.13%
All Time Low Date	2025-04-09
ATR	0.43
Beta	1.93
Beta1y	5.76
Beta2y	3.55
Ch YTD	264.4
High	5.1
High52	6.95
High52 Date	2026-04-10
High52ch	-29.21%
Low	4.71
Low52	1.21
Low52 Date	2025-11-07
Low52ch	305.94%
Ma50ch	16.84%
Premarket Change Percent	4.28
Premarket Price	$4.87
Premarket Volume	3,928
Price vs 200-day SMA	68.55%
RSI	58.45
RSI Monthly	46.8
RSI Weekly	59.8
Sharpe ratio	1.54x
Sortino ratio	3.36
Total Return	-0.34%
Tr YTD	264.4
Tr1m	6.73%
Tr1w	10.56%
Tr3m	24.24%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	6
Analyst Price Target Top	$8.4
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.46
Operating Income	$-142.1M
Price target	$6.67
Price Target Change	$35.57
Price Target Change Top	$70.73

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	48,556,433%
Float Percent	68.21%
Shares Insiders	2.16%
Shares Institutions	50.79%
Shares Out	71,186,348
Shares Qo Q	-1.95%
Shares Yo Y	0.34%
Short Float	12.66%
Short Ratio	4.37
Short Shares	8.63

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-143M
Adjusted OCF	-143,000,000
Average Volume	1,207,825.15x
Bv Per Share	2.57
CAPEX	$-34,000
Ch1m	6.73
Ch1w	10.56
Ch1y	264.4
Ch3m	24.24
Ch3y	-81.6
Ch5y	-90.99
Ch6m	96.02
Change	5.35%
Change From Open	2.93
Close	4.67
Days Gap	2.36
Depreciation Amortization	628,000
Dollar Volume	4,934,115.5
Earnings Date	2026-08-07
Earnings Time	amc
EBIT	$-145M
EBITDA	$-144.4M
EPS	$-1.74
F Score	0
FCF	$-125.6M
FCF EV Yield	-70.91x
FCF Per Share	$-1.76
Financing CF	-5,594,000
Fiscal Year End	December
Founded	2,014
Income Tax	$562,000
Investing CF	121,162,000
Ipr	-72.67
Iprfo	-80.48
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-26
Ma150	3.41
Ma150ch	44.2%
Ma20	4.71
Ma20ch	4.37%
Net CF	-9,999,000
Next Earnings Date	2026-08-10
Open	4.78
Optionable	Yes
Position In Range	53.85
Post Close	4.92
Postmarket Change Percent	0.05
Postmarket Price	$4.92
Ppne	28,248,000
Pre Close	4.67
Price Date	2026-07-30
Ptbv Ratio	1.92
Relative Volume	0.83x
Share Based Comp	17,433,000
Tr6m	96.02%
Us State	California
Volume	1,002,869

Zentalis Pharmaceuticals, Inc. (ZNTL)

Coverage state: Market snapshot only — no published research

Generate the first ZNTL analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ZNTL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ZNTL indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ZNTL

Frequently asked questions